Company Profile
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Latest News
CORSAIR Collaborates with AMD to Showcase AI Compute at AMD Advancing AI 2026
Viemed Healthcare Announces Second Quarter 2026 Earnings Conference Call Details
GL Communications Introduces PacketScan Webâ„¢ for Browser-Based Packet Analysis
Advanced Veterinary Pharmacovigilance: Online Course Deepens PSMF, Signal Detection, and Inspection-Readiness Skills
VMD CORP TO DELIVER PASSENGER AND BAGGAGE SCREENING SERVICES AT SAN FRANCISCO INTERNATIONAL AIRPORT
| Sector | Healthcare |
| Industry | Medical Devices |
| Website | https://www.viemed.com |
| Audit Risk | 5 |
| Board Risk | 6 |
| Overall Risk | 5 |
| Market Cap | 451.22M |
| Trailing P/E | 31.81 |
| Forward P/E | 29.43 |
| Trailing Annual Div. Rate | 0 |
| Trailing Annual Div. Yield | 0.00% |
| Trailing EPS | 0.37 |
| Forward EPS | 0.4 |
| Book Value | 3.72 |
| Price-to-Book | 3.16 |
| Enterprise-to-Revenue | 1.59 |
| Enterprise-to-EBITDA | 8.35 |
| Short Ratio | 2 |
| Earnings Date | 08/03/2026 |
| Earnings Call Date | 08/04/2026 |
| Revenue Average | 78.00M |
| Revenue Low | 77.80M |
| Revenue High | 78.20M |